Evaluating Alcohol Use in Alcoholic Liver Disease
Status: | Recruiting |
---|---|
Conditions: | Gastrointestinal |
Therapuetic Areas: | Gastroenterology |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 3/15/2019 |
Start Date: | November 27, 2016 |
End Date: | November 1, 2027 |
Contact: | Nicole T Shen, MD |
Email: | nts9004@nyp.org |
Phone: | 3146095911 |
This prospective, analytic observational study will investigate alcohol recidivism in
patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver
disease are considered for inclusion. Subjects able to give consent are included.
patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver
disease are considered for inclusion. Subjects able to give consent are included.
This is a longitudinal observational study. Subjects with a diagnosis of alcoholic liver
disease (acute alcoholic hepatitis or alcoholic cirrhosis) who present to Weill Cornell
Medical Center or Columbia University Medical Center New York Presbyterian Hospital or the
Gastroenterology and Hepatology Clinic will be invited to join this study, which entails a
survey at baseline and follow-up at 3, 6, 9, 12, 15, and 18 months and then at 2, 5, and 10
years. Follow-up will consist of a chart review, a phone or in person interview, and most
recent clinic visit interview for alcohol recidivism. The clinical providers will be blinded
to the survey results.
disease (acute alcoholic hepatitis or alcoholic cirrhosis) who present to Weill Cornell
Medical Center or Columbia University Medical Center New York Presbyterian Hospital or the
Gastroenterology and Hepatology Clinic will be invited to join this study, which entails a
survey at baseline and follow-up at 3, 6, 9, 12, 15, and 18 months and then at 2, 5, and 10
years. Follow-up will consist of a chart review, a phone or in person interview, and most
recent clinic visit interview for alcohol recidivism. The clinical providers will be blinded
to the survey results.
Inclusion Criteria:
- alcoholic liver disease able to consent
Exclusion Criteria:
- without alcoholic liver disease unable to consent
We found this trial at
1
site
630 West 168th Street
New York, New York 10021
New York, New York 10021
Phone: 314-609-5911
Click here to add this to my saved trials